Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01295268 · ClinicalTrials.gov registry record · NA
Study of Emu Oil vs. Placebo for Vulvar Pain in Women.
A NA study, sponsored by Corewell Health East.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT01295268: Clinical Trial NA study, sponsored by Corewell Health East.
NCT01295268 is a NA study that was terminated before completion, run by Corewell Health East. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01295268, a NA study, was terminated before completion, sponsored by Corewell Health East.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
The goal of this study is to determine if vulvar (external female genitalia) pain is decreased with emu oil over a similar placebo oil (no active ingredient) by using measurement devices, examinations, and questionnaires. Topical emu oil has not been scientifically studied for this condition yet, but related reports show no significant side effects or potential benefits. A total of 30 women will participate in the study at William Beaumont Hospital, Royal Oak.
Primary Outcome
Those "moderately" or "markedly" improved on the GRA are responders
Interventions
- OTHER Emu Oil
- OTHER Inert oil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2011-02 |
| Est. Completion | 2011-08 |
| Phase | NA |
Why NCT01295268 stopped before completion
NCT01295268 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Emu Oil is the first listed.
NCT01295268 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01295268 about?
NCT01295268 is a clinical study titled "Study of Emu Oil vs. Placebo for Vulvar Pain in Women.". The goal of this study is to determine if vulvar (external female genitalia) pain is decreased with emu oil over a similar placebo oil (no active ingredient) by using measurement devices, examinations, and questionnaires. Topical emu oil has not been scientifically studied for this condition yet, bu...
What is the current status of trial NCT01295268?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2011-02. Estimated completion is 2011-08.
What interventions are being tested in trial NCT01295268?
The interventions under investigation include: Emu Oil (OTHER), Inert oil (OTHER).
Who is sponsoring clinical trial NCT01295268?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01295268's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia